TerrAscend Stock (CSE: TER) (OTCQX: TRSSF) - Investor Dashboard
|Employees:||249 as of 5/15/19|
|CEO:||Dr. Michael Nashat|
TerrAscend – Management Team
Dr. Michael Nashat – CEO
Michael Nashat has over 12 years of experience in patient care, quality assurance, medical and regulatory affairs and R&D. Prior to joining TerrAscend, Mr. Nashat was the Executive Director of OnPharm Independent Pharmacy Group, which represents over 300 pharmacies. A former board member of Ontario College of Pharmacists, Canadian Association of Chain Drug Stores and the Ontario Ministry of Health and Long-Term Care’s Pharmacy Council.
Adam Kozak – Chief Financial Officer
Mr Kozak brings with him a wealth of experience from Loblaw Companies Limited, where he was most recently Senior Director of Finance. During his tenure, Adam led initiatives in mergers and integration, process re-engineering and analytics.
Jason Wild – Chairman
Jason Wild is the President and Chief Investment Officer of JW Asset Management, LLC. Mr. Wild received his license as a pharmacist in 1997, and subsequently founded JW Asset Management, LLC in 1998. The firm has a strong history of finding opportunities within the specialty pharmaceutical sector. He is a graduate of the Arnold and Marie Schwartz College of Pharmacy where he received a bachelor’s degree in Pharmacy.
Matthew J. Johnson – President, TerrAscend Corp. and TerrAscend USA
Matthew J. Johnson is responsible for leading TerrAscend’s U.S. operations. He comes to the company with more than 25 years of experience in the healthcare industry. He has held leadership roles at companies including AbbVie and Baxter Healthcare Corporation. Mr. Johnson earned his MBA from the Kellogg Graduate School of Management at Northwestern University and a BA in economics from the University of Vermont.
Significant Insider Ownership
Chairman Jason Wild (JW Asset Management)
35,000 Proportionate Voting Shares shares, 1000-1 conversion rights
CEO Michael Nashat
Director Vijay Sappani
5.01mm shares (Ela Family Trust)
Director Basem Hanna
4.03mm shares (Hanna Family Trust)
New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. TerrAscend, Inc. is a client of NCV Media, LLC. Read our full disclaimer.